RENOVACARE, INC.: 10-Q filed 2021-11-12
What RENOVACARE, INC. reported in its quarterly report filed 2021-11-12 (fiscal Q3 2021): 26 published measures, 76 facts as tagged in accession 0001171843-21-007881.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2021-11-12
- Fiscal period
- fiscal Q3 2021
- Accession
- 0001171843-21-007881 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All RENOVACARE, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | 4,192,191 | USD | |
| At 2020-12-31 | 8,395,944 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | 713,317 | USD | |
| At 2020-12-31 | 1,317,169 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | 3,478,874 | USD | |
| At 2021-06-30 | 4,930,909 | USD | |
| At 2021-03-31 | 5,665,021 | USD | |
| At 2020-12-31 | 7,078,775 | USD | |
| At 2020-09-30 | 8,588,649 | USD | |
| At 2020-06-30 | 10,025,801 | USD | |
| At 2020-03-31 | 11,450,872 | USD | |
| At 2019-12-31 | 12,159,862 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-07-01 to 2021-09-30 | -1,698,285 | USD | 92 |
| 2021-01-01 to 2021-09-30 | -3,127,488 | USD | 273 |
| 2020-07-01 to 2020-09-30 | -2,817,964 | USD | 92 |
| 2020-01-01 to 2020-09-30 | -7,004,310 | USD | 274 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-09-30 | -3,991,204 | USD | 273 |
| 2020-01-01 to 2020-09-30 | -3,464,685 | USD | 274 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-01-01 to 2020-09-30 | 41,273 | USD | 274 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-01-01 to 2020-09-30 | -49,268 | USD | 274 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | -32,895,669 | USD | |
| At 2020-12-31 | -29,768,181 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-07-01 to 2021-09-30 | 87,352,364 | shares | 92 |
| 2021-01-01 to 2021-09-30 | 87,352,364 | shares | 273 |
| 2020-07-01 to 2020-09-30 | 87,352,364 | shares | 92 |
| 2020-01-01 to 2020-09-30 | 87,352,364 | shares | 274 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | 31,594 | USD | |
| At 2020-12-31 | 38,640 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-07-01 to 2021-09-30 | 246,250 | USD | 92 |
| 2021-04-01 to 2021-06-30 | 243,979 | USD | 91 |
| 2021-01-01 to 2021-03-31 | 352,063 | USD | 90 |
| 2020-07-01 to 2020-09-30 | 1,119,815 | USD | 92 |
| 2020-04-01 to 2020-06-30 | 1,586,522 | USD | 91 |
| 2020-01-01 to 2020-03-31 | 465,763 | USD | 91 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-07-01 to 2021-09-30 | -1,700,524 | USD | 92 |
| 2021-01-01 to 2021-09-30 | -3,323,152 | USD | 273 |
| 2020-07-01 to 2020-09-30 | -2,842,879 | USD | 92 |
| 2020-01-01 to 2020-09-30 | -7,115,700 | USD | 274 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | 3,886,080 | USD | |
| At 2020-12-31 | 7,979,244 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | 713,317 | USD | |
| At 2020-12-31 | 1,288,562 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-07-01 to 2021-09-30 | 1,700,524 | USD | 92 |
| 2021-01-01 to 2021-09-30 | 3,323,152 | USD | 273 |
| 2020-07-01 to 2020-09-30 | 2,842,879 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 7,115,700 | USD | 274 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-07-01 to 2021-09-30 | 744,625 | USD | 92 |
| 2021-01-01 to 2021-09-30 | 2,503,487 | USD | 273 |
| 2020-07-01 to 2020-09-30 | 1,551,989 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 3,091,383 | USD | 274 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | 87,352,364 | shares | |
| At 2020-12-31 | 87,352,364 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | 36,373,669 | USD | |
| At 2020-12-31 | 36,846,082 | USD |
Operating lease right-of-use asset
Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | 41,171 | USD | |
| At 2020-12-31 | 79,462 | USD |
Operating lease liability
Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | 43,192 | USD | |
| At 2020-12-31 | 79,732 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | 152,854 | USD | |
| At 2020-12-31 | 152,854 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | 72,497 | USD | |
| At 2020-12-31 | 137,749 | USD |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-07-01 to 2021-09-30 | -1,698,285 | USD | 92 |
| 2021-04-01 to 2021-06-30 | -911,961 | USD | 91 |
| 2021-01-01 to 2021-03-31 | -517,242 | USD | 90 |
| 2020-07-01 to 2020-09-30 | -2,817,964 | USD | 92 |
| 2020-04-01 to 2020-06-30 | -3,011,593 | USD | 91 |
| 2020-01-01 to 2020-03-31 | -1,174,753 | USD | 91 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-09-30 | 7,046 | USD | 273 |
| 2020-01-01 to 2020-09-30 | 309 | USD | 274 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-07-01 to 2021-09-30 | 2,239 | USD | 92 |
| 2021-01-01 to 2021-09-30 | 195,664 | USD | 273 |
| 2020-07-01 to 2020-09-30 | 24,915 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 111,390 | USD | 274 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-09-30 | -567,312 | USD | 273 |
| 2020-01-01 to 2020-09-30 | 416,045 | USD | 274 |
Inspect the source
- Entity
- RENOVACARE, INC. / CIK 0001016708
- Captured
- SEC response SHA-256
9487b64abbea883e1831cb5c68f7e4fad6892ca4a6b733f29ee7e3c3b50f65e4
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001016708.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))